Question 1

Biomanufacturing is strictly limited to creating human medicines and vaccines.

Accepted Answer

It encompasses producing sustainable bio-based alternatives to petrochemicals, biopolymers, smart functional foods, and carbon capture mechanisms.

Question 2

Biofoundries are just large manufacturing factories for mass production.

Accepted Answer

They are advanced, open-access R&D ecosystems that integrate AI, synthetic biology, design, prototyping, and testing, acting as a bridge between lab research and commercial manufacturing rather than just a final assembly line.

Question 3

The BioE3 policy is an initiative of the Ministry of Environment, Forest and Climate Change.

Accepted Answer

The nodal implementing agency is the Department of Biotechnology (DBT) under the Ministry of Science and Technology.

Question 4

Consider the following statements regarding the BioE3 Policy and the recently launched National Biofoundry Network:
1. The nodal ministry responsible for implementing the BioE3 policy is the Ministry of Environment, Forest and Climate Change due to its focus on Net Zero goals.
2. The National Biofoundry Network integrates six premier scientific institutions to provide shared pilot-scale biomanufacturing infrastructure.
3. One of the six thematic focus areas of the BioE3 policy is Carbon Capture and its Utilization.
How many of the above statements are correct?

Accepted Answer

(b) Only two — Statement 1 is incorrect: The nodal ministry is the Ministry of Science and Technology (implemented by the Department of Biotechnology - DBT), not the MoEFCC. Statement 2 is correct: It integrates six premier institutions (such as ICGEB, NABI, and NCCS) to bridge the lab-to-market gap. Statement 3 is correct: The BioE3 policy targets 6 strategic sectors, including carbon capture & its utilization, high-value chemicals, smart proteins, precision biotherapeutics, climate-resilient agriculture, and marine/space research.

Question 5

Match the following institutions part of the National Biofoundry Network (List I) with their designated core biomanufacturing hub focus (List II):

List I (Institution)
A. National Agri-Food and Biomanufacturing Institute (NABI), Punjab
B. International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi
C. Translational Health Science and Technology Institute (THSTI), Faridabad
D. Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Mumbai

List II (Focus Area)
1. Bio-Enabler Hub
2. Advanced Cancer Cell Therapy Hub
3. Microbial Biomanufacturing
4. Agri-Food Bio-Hub

Select the correct answer using the code given below:

Accepted Answer

(a) A-4, B-3, C-1, D-2 — Under the integrated National Biofoundry Network, NABI (Punjab) focuses on the Agri-Food Bio-Hub (A-4). ICGEB (New Delhi) focuses on Microbial Biomanufacturing (B-3). THSTI (Faridabad) functions as the Bio-Enabler Hub (C-1). ACTREC (Mumbai) is dedicated to the Advanced Cancer Cell Therapy Hub (D-2). This showcases the highly specialized, collaborative nature of the network.

Question 6

Assertion (A): The establishment of National Biomanufacturing Hubs and Biofoundries aims to solve the 'valley of death' in India's biotechnology startup ecosystem.
Reason (R): While India has over 100 bio-incubation centres for early-stage lab research, it previously lacked the shared pilot-scale and pre-commercial scale-up infrastructure required to test and commercialize synthetic biology innovations.
Select the correct answer from the codes given below:

Accepted Answer

(a) Both A and R are true and R is the correct explanation of A. — The 'valley of death' in biotech startups refers to the severe funding and infrastructure gap between a successful lab-scale proof of concept and actual commercial manufacturing. Assertion A is true as the BioE3 policy explicitly targets this gap. Reason R is true and correctly explains A, because past initiatives (like BIRAC's BioNEST) successfully funded early-stage incubators, but innovators hit a roadblock when they needed expensive pilot-scale bioreactors and regulatory-grade testing facilities, which the new Biofoundries now provide.

India Launches National Biomanufacturing Hubs

Launch of National IED Data Management System